Drug intelligence / Profile preview

APB-G001

Development stage
Preclinical
Lead developer
APITBIO
Modality
mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antibody-Based Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

APB-G001 is a preclinical-stage mRNA-encoded antibody therapeutic being developed by APITBIO, a South Korean biotechnology company. The drug utilizes APITBIO's proprietary modular antibody mRNA production technology combined with a lipid nanoparticle (LNP) drug delivery system developed in collaboration with Inventage Lab. As an mRNA-encoded antibody, APB-G001 represents an innovative modality that uses messenger RNA to instruct the patient's own cells to produce therapeutic antibodies *in vivo*, rather than administering pre-manufactured protein antibodies. While the specific molecular target and primary indication remain undisclosed, the candidate is currently in the discovery phase and is available for co-research partnerships.

Beyond the preview

Go deeper on APB-G001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APB-G001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call